How many insider trades does FilingIQ track for ALZN?

FilingIQ tracks 203 Form 4 insider transactions for ALZN (Alzamend Neuro, Inc.), covering filings from Jun 15, 2021 onwards. 1 of those were filed in the last 90 days.

Are ALZN insiders net buyers or net sellers?

Across the full Form 4 history for ALZN, 128 transactions (63%) were open-market purchases and 35 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ALZN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ALZN in?

Alzamend Neuro, Inc. (ALZN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $7.34M.

ALZN insider trading

NasdaqCM Healthcare

Alzamend Neuro, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

203

Last 90 days

Buys / sells

63% / 17%

Market cap

$7.34M

About Alzamend Neuro, Inc.

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Company website: www.alzamend.com

ALZN insider activity at a glance

FilingIQ has scored 203 insider transactions for ALZN since Jun 15, 2021. The most recent filing in our index is dated Apr 14, 2026.

Across the full history, 128 open-market purchases and 35 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ALZN insider trades is 47.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ALZN trades on FilingIQ Raw filings on SEC EDGAR

Latest ALZN Form 4 filings

Katzoff David J Chief Financial Officer

P Sep 26, 2023

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ALZN?: FilingIQ tracks 203 Form 4 insider transactions for ALZN (Alzamend Neuro, Inc.), covering filings from Jun 15, 2021 onwards. 1 of those were filed in the last 90 days.
Are ALZN insiders net buyers or net sellers?: Across the full Form 4 history for ALZN, 128 transactions (63%) were open-market purchases and 35 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ALZN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ALZN in?: Alzamend Neuro, Inc. (ALZN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $7.34M.

Methodology & sources

Every ALZN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.